SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences informs about closure of trading window

29 Mar 2022 Evaluate

Kimia Biosciences has informed that in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Equity Shares of the Company by Designated Persons (and their immediate relatives) shall remain closed from Friday, 1st April, 2022 up to the completion of 48 hours after the declaration of unaudited Financial Results of the Company for the 4th quarter ended 31st March 2022 to the Stock Exchange.

The above information is a part of company’s filings submitted to BSE.

Kimia Biosciences Share Price

36.49 -1.48 (-3.90%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×